Frequently Asked Questions Research References Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation (Hsieh et al., J Mol Med, 2017) BPC 157 promotes tendon healing via tendon outgrowth, cell survival and cell migration, FAK and paxillin phosphorylation (Chang et al., J Appl Physiol, 2011) Regeneration or Risk
Medications that have been suggested for the symptoms of fatigue, brain fog, postexertional malaise, orthostatic intolerance, or allergy/inflammation had less often been tried, despite their overall accessibility to generalist clinicians
This is one of the most common questions we hear, and its a fair one
From discovery to the coming generation of histone deacetylase inhibitors